News
October 2, 2024

Regenstrief researcher awarded $1.9 million CDC grant

Award funds study to improve long-term outcomes of those living with congenital heart defects

Jill Inderstrodt, PhD, MPH, received notification of a five-year, $1.9 million collaborative grant to improve health and the care of people living with congenital heart defects (CHD).

Awarded by the Centers for Disease Control and Prevention, Dr. Inderstrodt will lead a multidisciplinary team from the Indiana University Fairbanks School of Public Health and the Regenstrief Institute. Also part of the research team is Brian Dixon, PhD, MPA, a Regenstrief researcher, Fairbanks School professor and interim director of the Regenstrief Center for Biomedical Informatics.

“I am honored to lead this initiative alongside a dedicated team of experts,” said Dr. Inderstrodt, assistant professor of health policy and management at the Fairbanks School. “By integrating clinical, administrative and public health data, we have the opportunity to not only identify and track individuals with congenital heart defects, but also improve the long-term outcomes of those living with CHD. This level of collaboration will allow us to make effective policy recommendations that will enhance the care and support of these individuals throughout their lives.”

The project has the following four aims:

  1. Identify cases of congenital heart defects among children, adolescents and adults living in Indiana.
  2. Integrate clinical and administrative data about individuals living with congenital heart defects.
  3. Utilize integrated data to measure outcomes for people living with congenital heart defects.
  4. Make policy recommendations so that individuals with congenital heart failure can experience long-term health.

The grant, “Advancing Surveillance of Congenital Heart Defects: Using Unparalleled Informatics and Data Science to Improve the Health of Children, Adolescents, and Adults,” will include collaboration across the Fairbanks School’s Center for Health Policy, Regenstrief Institute, Indiana Department of Health, Riley Hospital for Children and local nonprofit organizations. In addition to Drs. Inderstrodt and Dixon, the project team includes Fairbanks School’s Katy Hilts, PhD, MPH, and staff from the Center for Health Policy.

Partners

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief Institute research scientists and professional staff joined presenters from around the world at the MedInfo 2025 conference from